Abstract Introduction Phosphodiesterase-type-5-inhibitors (PDE5i) represent first-line FDA-approved oral treatments for erectile dysfunction (ED). However, because their mode of action is dependent on the production nitric oxide (NO) from nerve endings, patients that suffer neurogenic ED (for example, following procedures radical prostatectomy (RP) or resulting diabetes) are commonly refractory...

A bstract θ 13 oscillation analysis based on the observed antineutrino rates at Double Chooz far and near detectors for different reactor power conditions is presented. This approach provides a so unique simultaneous determination of total background without relying any assumptions specific contributions. The comprises 865 days data collected in both with least one operation. results are enhanc...